KAZANTSEVA, A.V.,
DAVYDOVA, YU.D.,
ENIKEEVA, R.F.,
LOBASKOVA, M.M.,
MUSTAFIN, R.N.,
MALYKH, S.B.,
TAKHIROVA, Z.R.,
KHUSNUTDINOVA, E.K. (2020) level. Limitations: A hypothesis driven candidate gene approach, which examined a limited number
of ketotiphen, Lydase and Aevit, as well as monotherapy with an ATP-independent inhibitor of mitogen-
activated